Navigation Links
Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research

cancer in the developing world will be presented in this presentation. -- Sunday, June 3, 2:00 PM - 6:00 PM, S Hall A2, Poster Number W2. About Eloxatin(R) Indications and Usage

Eloxatin(R) (oxaliplatin for injection), a DACH platinum, is approved in combination with infusional 5-FU/LV for the second-line treatment of patients with advanced carcinoma of the colon or rectum. In 2004, Eloxatin received additional approval for the first-line treatment of these patients. Based on data showing improvement in disease-free survival, Eloxatin was also approved in 2004 for use in combination with infusional 5-FU/LV in adjuvant (post- surgery) treatment of stage III colon cancer patients.

Clinical Safety Considerations

Eloxatin(R) should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents.

Appropriate management of therapy and complications is possible only when adequate diagnostic and treatment facilities are readily available.

Anaphylactic-like reactions to Eloxatin(R) have been reported and may occur within minutes of Eloxatin(R) administration. Epinephrine, corticosteroids, and antihistamines have been employed to alleviate symptoms, and discontinuation of Eloxatin(R) therapy may be required.


    -- Eloxatin(R) should not be administered to patients with a history of

       known allergy to Eloxatin(R) or other platinum compounds.

       Hypersensitivity and anaphylactic/anaphylactoid reactions to

       Eloxatin(R) have been reported and were similar in nature and severity

       to those reported with other platinum compounds (ie, rash, urticaria,

       erythema, pruritus, and, rarely, bronchospasm and hypotension). These

       reactions occur within minutes of administration and should be managed

       with appropriate supportive therapy. Drug-related deaths from this

       reaction have been reported


    -- Eloxatin(R) may cause fet
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:1/15/2014)... Jan. 15, 2014 Most osteoporosis patients want a ... recent online survey* sponsored by Mission Pharmacal Company. The ... Osteoporosis Foundation online support community, revealed that 74 percent ... comes in a form other than a pill or ...
(Date:1/15/2014)... 2014  Celsion Corporation (the "Company") (NASDAQ: CLSN ... institutional investors to purchase an aggregate of approximately $15 ... registered direct offering, led by a dedicated health care ... agreements with these investors pursuant to which the Company ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... WORTH, Texas, March 22, 2012  The Board of Directors of ... innovator in advanced wound care solutions, announced today that Robert ... of the Company.  In addition, Scott A. Haire has resigned ... Executive Officer of the Company, and Deborah Jenkins Hutchinson has ...
... 22, 2012  Argon Medical Devices, Inc. announced today ... catheter, licensed from Rex Medical, LP, designed to ... treatments. "UltraStream provides clinicians with an ... life for their patients," commented George Leondis, President ...
Cached Medicine Technology:Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 2Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 3Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter 2
(Date:7/11/2014)... Seattle, WA (PRWEB) July 11, 2014 ... but the rate of return to play has not ... at the American Orthopaedic Society for Sports Medicine’s ( ... for NFL players is approximately 90 percent no matter ... study highlighted the success rate of return to play ...
(Date:7/11/2014)... SEATTLE, WA Anterior Cruciate Ligament (ACL) reconstructions occur ... of material used to create a new ligament may ... researchers presenting their work today at the Annual Meeting ... , "Our study results highlight that in ... donor) fail more frequently than using autografts (tissue harvested ...
(Date:7/11/2014)... Woodland Hills permanent teeth in one day ... Art Institute in Woodland Hills and Oxnard, Calif., will speak ... Del Rey, Calif. , The award-winning prosthodontist, international speaker ... teeth in one day dental procedure at 1:30 p.m. Friday, ... developed 15 years ago, Dr. Jivraj said. Getting new teeth ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The World Cup ... according to recent reports , many star soccer players left ... in the media to American football when it comes to ... risk is always there. While none of the soccer superstars ... possibility remains. Beverly Hills spine surgeon Dr. Gravori reveals some ...
(Date:7/11/2014)... On Tuesday, July 9, Eric D. ... office joined CBS affiliate WUSA’s Andrea Roane on ... audience about the number of ways Shady Grove Fertility ... possible for women after they undergo cancer treatment. ... in the developing field known as oncofertility which Dr. ...
Breaking Medicine News(10 mins):Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL reconstructions may last longer with autografts 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 3Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 4Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 5Health News:As World Cup Comes to an End, Injuries are Star of the Show 2Health News:As World Cup Comes to an End, Injuries are Star of the Show 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4
... choose to admit it or not, we all experience memory ... memory may be a result of having too many other ... passed. However, previous studies have indicated that a specific type ... reasons. Boundary extension is a mistake that we often make ...
... get into fights , , WEDNESDAY, Oct. 29 (HealthDay News) -- ... entertainment in the media are far less likely to engage ... at a slice in time, so I can,t tell you ... the reverse that violent kids are looking for violent media," ...
... study raises the question, do barriers to health ... risk of tuberculosis? The study, published in the ... Diseases and now available online, suggests that ... seeking care than documented immigrants or U.S.-born patients, ...
... Caregivers strike at 10 hospitals owned by Sutter Health ... Members of SEIU,United Healthcare Workers-West (UHW) are on strike ... hospitals owned by Daughters of Charity,Health System (DOCHS), and ... and bad-faith negotiation by hospital management., At three ...
... and Online Content to Fight,Mental Health Stigma and ... YORK, Oct. 29 mtvU, MTV,s 24-hour college ... to reduce emotional,distress and prevent suicide among college ... campaign with new content launching,today that encourages students ...
... and climate change as culprits , , WEDNESDAY, Oct. 29 ... year from infectious diseases, and that number could increase ... news was delivered in a report, Germs Go ... America , released Wednesday by the Trust for America,s ...
Cached Medicine News:Health News:Our cheatin' brain: The brain's clever way of showing us the world as a whole 2Health News:Less Exposure to Violent Media Makes Youths Less Aggressive 2Health News:Less Exposure to Violent Media Makes Youths Less Aggressive 3Health News:Health-care barriers for undocumented immigrants: Raising tuberculosis risk? 2Health News:United Healthcare Workers Stand Up For Patients in Statewide Hospital Strike 2Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 2Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 3Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 4Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 5Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 6Health News:Threat From Infectious Diseases Growing 2Health News:Threat From Infectious Diseases Growing 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: